BMP9/10 in Pulmonary Vascular Complications of Liver Disease
- 15 June 2020
- journal article
- letter
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 201 (12), 1575-1578
- https://doi.org/10.1164/rccm.201912-2514le
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Characterization of GDF2 Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2020
- Bone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2019
- A heterodimer formed by bone morphogenetic protein 9 (BMP9) and BMP10 provides most BMP biological activity in plasmaOnline Journal of Public Health Informatics, 2018
- Clinical Impact of Intrapulmonary Vascular Dilatation in Candidates for Liver TransplantSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2018
- Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertensionNature Medicine, 2015
- Normal and abnormal pulmonary arteriovenous shunting: occurrence and mechanismsCardiology in the Young, 2013
- BMP9 is produced by hepatocytes and circulates mainly in an active mature form complexed to its prodomainCellular and Molecular Life Sciences, 2011
- Impact of Hepatopulmonary Syndrome on Quality of Life and Survival in Liver Transplant CandidatesGastroenterology, 2008
- Bone Morphogenetic Protein-9 Is a Circulating Vascular Quiescence FactorCirculation Research, 2008
- Diagnosis of portopulmonary hypertension in candidates for liver transplantation: A prospective studyJournal of Hepatology, 2003